MedTrace Logo

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent

NCT01060306 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-02-24

No results posted yet for this study

Summary

PONTINA aims at assessing by optical coherence tomography the neointimal coverage of the biodegradable polymer-based Biolimus A9-eluting stent (Biomatrix stent) after full drug elution and polymer biodegradation (6 months), at one month after this time-point (7 months) and, as a comparator, of its bare metal stent counterpart (Gazelle stent) at 1 month after implantation.

Conditions

Sponsors & Collaborators

  • Ospedale Santa Maria Goretti

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-08-31
Completion
2011-01-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01060306 on ClinicalTrials.gov